Patent 9096684 was granted and assigned to Aileron Therapeutics on August, 2015 by the United States Patent and Trademark Office.
The present invention provides peptidomimetic macrocycles capable of modulating growth hormone levels and methods of using such macrocycles for the treatment of disease.